Etanercept Market - Global Industry Analysis

Etanercept Market: by Application (Psoriasis, Arthritis, and Spondylitis): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Published Date: 07-Nov-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-4989 Status : Published

Etanercept Market: by Application (Psoriasis, Arthritis, and Spondylitis): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Description

The report covers forecast and analysis for the etanercept market on a global and regional level. The study provides historic data from 2016 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the etanercept market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the etanercept market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the etanercept market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product and services segment is benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the etanercept market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the etanercept market on global and regional basis.

Etanercept is a biopharmaceutical that is used to treat autoimmune disorders. Etanercept interferes with tumor necrosis factor (TNF) by performing as a TNF inhibitor. The biopharmaceutical is U.S. FDA approved to treat psoriatic arthritis, juvenile idiopathic arthritis, rheumatoid arthritis, ankylosing spondylitis, and plaque psoriasis.

Factors such as growing incidence of spondylitis and arthritis, rising cases of obesity, growing number of accidents, efforts taken by governments to create awareness regarding biopharmaceuticals, and FDA approval will act as major driving factors in the growth of global etanercept market. Growing healthcare expenditure and investment in research and development will act as an opportunity for the market players in the etanercept market. Nonetheless, heavy regulations related to efficacy and safety of etanercept will restrict the growth of global etanercept market.

The global etanercept market has been split into application and region. Based on application, etanercept market has been segmented into psoriasis, arthritis, and spondylitis. The arthritis segment accounted for the highest market share in 2018 due to rise in cases of arthritis.

North America will be the leading region during the forecast period. Presence of key companies, rapid uptake of new treatment, and accessibility of modern treatment options will boost the market growth in this region. Europe is expected to be the second major market. The key reasons are presence of skilled physicians and high healthcare expenditure. Asia Pacific will grow at rapid rate over the forecast time-frame due to growing patient awareness, high cases of arthritis, and increase in accident cases. The market in Latin America will grow at a substantial rate during the estimate period. The Africa and Middle Eastern region is expected to exhibit definite progression in the anticipated time-frame.

The report also includes detailed profiles of key players such as Pfizer Inc., Takeda Pharmaceutical Company Ltd, Johnson & Johnson, GlaxoSmithKline Pharmaceuticals Ltd, Samsung Bioepis Co., Ltd., F. Hoffmann-La Roche Ltd, Cipla Limited, Novartis International AG, Celltrion Inc., and Immunex Corporation among others.

This report segments the Global Etanercept Market as follows:

Global Etanercept Market: By Application

  • Psoriasis
  • Arthritis
  • Spondylitis

Global Etanercept Market: By Region

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Etanercept Market, 2016-2025 (USD Million)
    • 2.2. Etanercept Market: Snapshot
  • Chapter 3. Etanercept Market - Industry Analysis
    • 3.1. KEYWORD #: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Driver 1
      • 3.2.2. Driver 2
    • 3.3. Restraints
      • 3.3.1. Restraint 1
      • 3.3.2. Restraint 2
    • 3.4. Opportunity
      • 3.4.1. Government funding and support
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Application
      • 3.6.2. Market attractiveness analysis by Region
  • Chapter 4. Etanercept Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Etanercept Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Application launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Etanercept Market -Application Analysis
    • 5.1. Global Etanercept Market overview: By Application type
      • 5.1.1. Global Etanercept Market share, By Application,2018 and 2025
    • 5.2. Psoriasis
      • 5.2.1. Global Etanercept Market by Psoriasis, 2016-2025 (USD Million)
    • 5.3. Arthritis
      • 5.3.1. Global Etanercept Marketby Arthritis, 2016-2025 (USD Million)
    • 5.4. Spondylitis
      • 5.4.1. Global Etanercept Market by Spondylitis, 2016-2025 (USD Million)
  • Chapter 6. Global Etanercept Market - Regional Analysis
    • 6.1. Global Etanercept Market overview: by Region
      • 6.1.1. Global Etanercept Marketshare, by Region, 2018 and 2025
    • 6.2. North America
      • 6.2.1. North America Etanercept Market, 2016-2025 (USD Million)
      • 6.2.2. North America Etanercept Market revenue, By Application,2016-2025 (USD Million)
      • 6.2.3. The U.S.
        • 6.2.3.1. The U.S.Etanercept Market revenue, By Application,2016-2025 (USD Million)
      • 6.2.4. Rest of North America
        • 6.2.4.1. Rest of North America Etanercept Market revenue, By Application,2016-2025 (USD Million)
    • 6.3. Europe
      • 6.3.1. Europe Etanercept Market, 2016-2025 (USD Million)
      • 6.3.2. Europe Etanercept Market revenue, By Application,2016-2025 (USD Million)
      • 6.3.3. UK
        • 6.3.3.1. U.K.Etanercept Marketrevenue, By Application,2016-2025 (USD Million)
      • 6.3.4. France
        • 6.3.4.1. France Etanercept Market revenue, By Application,2016-2025 (USD Million)
      • 6.3.5. Germany
        • 6.3.5.1. Germany Etanercept Market revenue, By Application,2016-2025 (USD Million)
      • 6.3.6. Rest of Europe
        • 6.3.6.1. Rest of Europe Etanercept Marketrevenue, By Application,2016-2025 (USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Etanercept Market, 2016-2025 (USD Million)
      • 6.4.2. Asia Pacific Etanercept Market revenue, By Application,2016-2025 (USD Million)
      • 6.4.3. China
        • 6.4.3.1. China Etanercept Market revenue, By Application,2016-2025 (USD Million)
      • 6.4.4. Japan
        • 6.4.4.1. Japan Etanercept Market revenue, By Application,2016-2025 (USD Million)
      • 6.4.5. India
        • 6.4.5.1. India Etanercept Market revenue, By Application,2016-2025 (USD Million)
      • 6.4.6. Rest of Asia Pacific
        • 6.4.6.1. Rest of Asia Pacific Etanercept Market revenue, By Application,2016-2025 (USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America Etanercept Market, 2016-2025 (USD Million)
      • 6.5.2. Latin America Etanercept Market revenue, By Application,2016-2025 (USD Million)
      • 6.5.3. Brazil
        • 6.5.3.1. Brazil Etanercept Marketrevenue, By Application,2016-2025 (USD Million)
      • 6.5.4. Rest of LatinAmerica
        • 6.5.4.1. Rest of LatinAmerica Etanercept Marketrevenue, By Application,2016-2025 (USD Million)
    • 6.6. The Middle East and Africa
      • 6.6.1. The Middle East and Africa Etanercept Market, 2016-2025 (USD Million)
      • 6.6.2. The Middle East and Africa Etanercept Marketrevenue, By Application,2016-2025 (USD Million)
  • Chapter 7. Company Profiles
    • 7.1. Pfizer Inc.
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Application Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Takeda Pharmaceutical Company Ltd
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Application Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Johnson & Johnson
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Application Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. GlaxoSmithKline Pharmaceuticals Ltd
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Application Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. Samsung Bioepis Co., Ltd.
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Application Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. F. Hoffmann-La Roche Ltd
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Application Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. Cipla Limited
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Application Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. Novartis International AG
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Application Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development
    • 7.9. Celltrion Inc.
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Application Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Development
    • 7.10. Immunex Corporation
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Application Portfolio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Development

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed